Upstream Bio

Upstream Bio

Biotechnology Research

Waltham, Massachusetts 5,334 followers

Developing treatments for inflammatory diseases

About us

We are advancing verekitug, a clinical-stage monoclonal antibody targeting an upstream driver of inflammatory response. Our experienced team is committed to leveraging verekitug’s unique mechanism of action to improve the treatment options for millions of patients living with severe inflammatory diseases.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Waltham, Massachusetts
Type
Public Company
Founded
2021
Specialties
inflammation and allergic

Locations

  • Primary

    890 Winter St

    Suite 200

    Waltham, Massachusetts 02451, US

    Get directions

Employees at Upstream Bio

Updates

Similar pages

Browse jobs

Funding